Charles River Associates (CRAI)
(Real Time Quote from BATS)
$166.69 USD
-0.34 (-0.20%)
Updated Sep 23, 2024 01:06 PM ET
1-Strong Buy of 5 1
C Value B Growth C Momentum B VGM
Income Statements
Fiscal Year end for Charles River Associates falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 624 | 591 | 566 | 508 | 451 |
Cost Of Goods | 440 | 410 | 400 | 371 | 318 |
Gross Profit | 184 | 181 | 166 | 138 | 134 |
Selling & Adminstrative & Depr. & Amort Expenses | 127 | 122 | 110 | 103 | 104 |
Income After Depreciation & Amortization | 58 | 59 | 56 | 35 | 29 |
Non-Operating Income | -1 | 2 | 0 | 0 | -1 |
Interest Expense | 4 | 2 | 1 | 1 | 1 |
Pretax Income | 52 | 59 | 54 | 34 | 27 |
Income Taxes | 14 | 15 | 13 | 9 | 6 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 38 | 44 | 42 | 25 | 21 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 38 | 43 | 42 | 25 | 21 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 83 | 84 | 82 | 60 | 51 |
Depreciation & Amortization (Cash Flow) | 26 | 26 | 26 | 25 | 21 |
Income After Depreciation & Amortization | 58 | 59 | 56 | 35 | 29 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 7.12 | 7.36 | 7.62 | 7.95 | 8.17 |
Diluted EPS Before Non-Recurring Items | 5.46 | 5.94 | 5.49 | 3.35 | 3.01 |
Diluted Net EPS (GAAP) | 5.39 | 5.91 | 5.45 | 3.07 | 2.53 |
Fiscal Year end for Charles River Associates falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 171.44 | 171.79 | 161.61 | 147.55 | 161.97 |
Cost Of Goods | 125.33 | 118.88 | 112.69 | 105.89 | 113.33 |
Gross Profit | 46.12 | 52.91 | 48.93 | 41.66 | 48.63 |
SG&A, R&D, and Dept/Amort Expenses | 34.83 | 33.29 | 31.78 | 30.87 | 32.72 |
Income After SG&A, R&D, and Dept/Amort Expenses | 11.29 | 19.62 | 17.15 | 10.79 | 15.91 |
Non-Operating Income | -0.19 | -0.14 | -0.99 | 0.76 | -0.69 |
Interest Expense | 1.48 | 0.46 | 0.60 | 1.03 | 1.62 |
Pretax Income | 9.61 | 19.01 | 15.56 | 10.52 | 13.61 |
Income Taxes | 3.08 | 5.32 | 4.10 | 1.93 | 4.10 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 6.54 | 13.69 | 11.46 | 8.60 | 9.51 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 6.54 | 13.69 | 11.46 | 8.60 | 9.51 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 6.91 | 7.01 | 7.06 | 7.08 | 7.08 |
Diluted EPS Before Non-Recurring Items | 1.83 | 1.96 | 1.63 | 1.13 | 1.42 |
Diluted Net EPS (GAAP) | 0.94 | 1.95 | 1.61 | 1.21 | 1.34 |